• Ultragenyx Pharmaceutical's (RARE) "Buy" Rating Reaffirmed at Canaccord Genuity Group

    Источник: Buzz FX / 12 ноя 2024 11:39:16   America/Chicago


    Ultragenyx Pharmaceutical's (RARE) "Buy" Rating Reaffirmed at Canaccord Genuity Group Written by MarketBeat November 12, 2024 Share Link copied to clipboard. Ultragenyx Pharmaceutical ( NASDAQ:RARE - Get Free Report ) 's stock had its "buy"
    Read more...
Опубликовать